Author: Florian Krammer

Downloads per author, site-wide

Preprints

Evaluation of immunological responses to third COVID-19 vaccine among people treated with sphingosine receptor-1 modulators and anti-CD20 therapy

No download data for this paper yet.

Robust spike antibody responses and increased reactogenicity in seropositive individuals after a single dose of SARS-CoV-2 mRNA vaccine

• Downloaded 108,703 times
• Download rankings, all-time:
  • Site-wide: 68
  • In allergy and immunology: 1
• Year to date:
  • Site-wide: 237
• Since beginning of last month:
  • Site-wide: 444

A serological assay to detect SARS-CoV-2 seroconversion in humans

• Downloaded 96,837 times
• Download rankings, all-time:
  • Site-wide: 79
  • In allergy and immunology: 2
• Year to date:
  • Site-wide: 1,548
• Since beginning of last month:
  • Site-wide: 2,174

Immunological memory to SARS-CoV-2 assessed for up to eight months after infection

• Downloaded 72,275 times
• Download rankings, all-time:
  • Site-wide: 119
  • In immunology: 3
• Year to date:
  • Site-wide: 1,130
• Since beginning of last month:
  • Site-wide: 1,630

Humoral immune response and prolonged PCR positivity in a cohort of 1343 SARS-CoV 2 patients in the New York City region

• Downloaded 36,473 times
• Download rankings, all-time:
  • Site-wide: 272
  • In infectious diseases: 103
• Year to date:
  • Site-wide: 9,589
• Since beginning of last month:
  • Site-wide: 18,560

SARS-CoV-2 infection induces robust, neutralizing antibody responses that are stable for at least three months

• Downloaded 18,464 times
• Download rankings, all-time:
  • Site-wide: 590
  • In infectious diseases: 212
• Year to date:
  • Site-wide: 17,802
• Since beginning of last month:
  • Site-wide: 24,290

Convalescent plasma treatment of severe COVID-19: A matched control study

• Downloaded 16,005 times
• Download rankings, all-time:
  • Site-wide: 704
  • In infectious diseases: 252
• Year to date:
  • Site-wide: 15,005
• Since beginning of last month:
  • Site-wide: 19,177

Introductions and early spread of SARS-CoV-2 in the New York City area

• Downloaded 15,924 times
• Download rankings, all-time:
  • Site-wide: 707
  • In infectious diseases: 254
• Year to date:
  • Site-wide: 6,964
• Since beginning of last month:
  • Site-wide: 8,877

Evidence of a significant secretory-IgA-dominant SARS-CoV-2 immune response in human milk following recovery from COVID-19

• Downloaded 11,760 times
• Download rankings, all-time:
  • Site-wide: 1,042
  • In infectious diseases: 343
• Year to date:
  • Site-wide: 4,818
• Since beginning of last month:
  • Site-wide: 4,285

Activity of convalescent and vaccine serum against a B.1.1.529 variant SARS-CoV-2 isolate

• Downloaded 10,871 times
• Download rankings, all-time:
  • Site-wide: 1,157
  • In infectious diseases: 373
• Year to date:
  • Site-wide: 581
• Since beginning of last month:
  • Site-wide: 19,024

Before the Surge: Molecular Evidence of SARS-CoV-2 in New York City Prior to the First Report

• Downloaded 9,785 times
• Download rankings, all-time:
  • Site-wide: 1,313
  • In infectious diseases: 406
• Year to date:
  • Site-wide: 48,811
• Since beginning of last month:
  • Site-wide: 20,991

Seroconversion of a city: Longitudinal monitoring of SARS-CoV-2 seroprevalence in New York City

• Downloaded 9,087 times
• Download rankings, all-time:
  • Site-wide: 1,432
  • In epidemiology: 187
• Year to date:
  • Site-wide: 23,129
• Since beginning of last month:
  • Site-wide: 36,628

Intranasal ChAdOx1 nCoV-19/AZD1222 vaccination reduces shedding of SARS-CoV-2 D614G in rhesus macaques

• Downloaded 6,483 times
• Download rankings, all-time:
  • Site-wide: 2,230
  • In microbiology: 176
• Year to date:
  • Site-wide: 10,053
• Since beginning of last month:
  • Site-wide: 14,297

Long-lasting neutralizing antibody responses in SARS-CoV-2 seropositive individuals are robustly boosted by immunization with the CoronaVac and BNT162b2 vaccines

• Downloaded 6,233 times
• Download rankings, all-time:
  • Site-wide: 2,355
  • In infectious diseases: 654
• Year to date:
  • Site-wide: 5,428
• Since beginning of last month:
  • Site-wide: 3,591

The plasmablast response to SARS-CoV-2 mRNA vaccination is dominated by non-neutralizing antibodies that target both the NTD and the RBD

• Downloaded 5,964 times
• Download rankings, all-time:
  • Site-wide: 2,492
  • In infectious diseases: 670
• Year to date:
  • Site-wide: 3,754
• Since beginning of last month:
  • Site-wide: 4,817

Safety and Immunogenicity of an Inactivated Recombinant Newcastle Disease Virus Vaccine Expressing SARS-CoV-2 Spike: Interim Results of a Randomised, Placebo-Controlled, Phase 1/2 Trial

• Downloaded 5,216 times
• Download rankings, all-time:
  • Site-wide: 3,003
  • In infectious diseases: 757
• Year to date:
  • Site-wide: 3,850
• Since beginning of last month:
  • Site-wide: 8,042

Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as vaccine candidate

• Downloaded 5,091 times
• Download rankings, all-time:
  • Site-wide: 3,112
  • In microbiology: 224
• Year to date:
  • Site-wide: 32,366
• Since beginning of last month:
  • Site-wide: 27,123

Mapping SARS-CoV-2 antigenic relationships and serological responses

• Downloaded 4,645 times
• Download rankings, all-time:
  • Site-wide: 3,496
  • In immunology: 191
• Year to date:
  • Site-wide: 216
• Since beginning of last month:
  • Site-wide: 1,005

SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study

• Downloaded 4,524 times
• Download rankings, all-time:
  • Site-wide: 3,641
  • In infectious diseases: 829
• Year to date:
  • Site-wide: 4,261
• Since beginning of last month:
  • Site-wide: 34,069

Safety and immunogenicity of a live recombinant Newcastle disease virus-based COVID-19 vaccine (Patria) administered via the intramuscular or intranasal route: Interim results of a non-randomized open label phase I trial in Mexico

• Downloaded 3,940 times
• Download rankings, all-time:
  • Site-wide: 4,380
  • In infectious diseases: 1,075
• Year to date:
  • Site-wide: 257
• Since beginning of last month:
  • Site-wide: 3,097

The E484K mutation in the SARS-CoV-2 spike protein reduces but does not abolish neutralizing activity of human convalescent and post-vaccination sera.

• Downloaded 3,883 times
• Download rankings, all-time:
  • Site-wide: 4,482
  • In infectious diseases: 955
• Year to date:
  • Site-wide: 11,125
• Since beginning of last month:
  • Site-wide: 11,213

Efficient mucosal antibody response to SARS-CoV-2 vaccination is induced in previously infected individuals

• Downloaded 3,688 times
• Download rankings, all-time:
  • Site-wide: 4,837
  • In allergy and immunology: 36
• Year to date:
  • Site-wide: 1,762
• Since beginning of last month:
  • Site-wide: 5,631

Quantifying absolute neutralization titers against SARS-CoV-2 by a standardized virus neutralization assay allows for cross-cohort comparisons of COVID-19 sera

• Downloaded 3,264 times
• Download rankings, all-time:
  • Site-wide: 5,770
  • In infectious diseases: 1,116
• Year to date:
  • Site-wide: 18,944
• Since beginning of last month:
  • Site-wide: 30,022

Seroprevalence of SARS-CoV-2 among children visiting a hospital during the initial Seattle outbreak

• Downloaded 3,217 times
• Download rankings, all-time:
  • Site-wide: 5,882
  • In infectious diseases: 1,108
• Year to date:
  • Site-wide: 56,480
• Since beginning of last month:
  • Site-wide: 54,481

mRNA-1273 but not BNT162b2 induces antibodies against polyethylene glycol (PEG) contained in mRNA-based vaccine formulations

• Downloaded 3,152 times
• Download rankings, all-time:
  • Site-wide: 6,053
  • In allergy and immunology: None
• Year to date:
  • Site-wide: 350
• Since beginning of last month:
  • Site-wide: 790

The inactivated NDV-HXP-S COVID-19 vaccine induces a significantly higher ratio of neutralizing to non-neutralizing antibodies in humans as compared to mRNA vaccines

• Downloaded 2,823 times
• Download rankings, all-time:
  • Site-wide: 7,125
  • In infectious diseases: 1,360
• Year to date:
  • Site-wide: 404
• Since beginning of last month:
  • Site-wide: 6,514

Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C)

• Downloaded 2,816 times
• Download rankings, all-time:
  • Site-wide: 7,145
  • In pediatrics: 23
• Year to date:
  • Site-wide: 33,264
• Since beginning of last month:
  • Site-wide: 41,500

The N501Y mutation in SARS-CoV-2 spike leads to morbidity in obese and aged mice and is neutralized by convalescent and post-vaccination human sera

• Downloaded 2,779 times
• Download rankings, all-time:
  • Site-wide: 7,287
  • In infectious diseases: 1,345
• Year to date:
  • Site-wide: 7,182
• Since beginning of last month:
  • Site-wide: 6,280

Introduction of two prolines and removal of the polybasic cleavage site leads to optimal efficacy of a recombinant spike based SARS-CoV-2 vaccine in the mouse model

• Downloaded 2,512 times
• Download rankings, all-time:
  • Site-wide: 8,480
  • In microbiology: 505
• Year to date:
  • Site-wide: 26,564
• Since beginning of last month:
  • Site-wide: 46,997

Subtle immunological differences in mRNA-1273 and BNT162b2 COVID-19 vaccine induced Fc-functional profiles

• Downloaded 2,503 times
• Download rankings, all-time:
  • Site-wide: 8,518
  • In immunology: 345
• Year to date:
  • Site-wide: 5,002
• Since beginning of last month:
  • Site-wide: 6,013

Antibody Immunological Imprinting on COVID-19 Patients

• Downloaded 2,463 times
• Download rankings, all-time:
  • Site-wide: 8,700
  • In infectious diseases: 1,414
• Year to date:
  • Site-wide: 45,622
• Since beginning of last month:
  • Site-wide: 37,685

Comparison of Transgenic and Adenovirus hACE2 Mouse Models for SARS-CoV-2 Infection

• Downloaded 2,208 times
• Download rankings, all-time:
  • Site-wide: 10,185
  • In microbiology: 582
• Year to date:
  • Site-wide: 48,116
• Since beginning of last month:
  • Site-wide: 40,085

Distinct systems serology features in children, elderly and COVID patients

• Downloaded 2,205 times
• Download rankings, all-time:
  • Site-wide: 10,210
  • In infectious diseases: 1,556
• Year to date:
  • Site-wide: 39,957
• Since beginning of last month:
  • Site-wide: 31,870

Neutralizing Antibody Responses in COVID-19 Convalescent Sera

• Downloaded 2,196 times
• Download rankings, all-time:
  • Site-wide: 10,279
  • In infectious diseases: 1,545
• Year to date:
  • Site-wide: 57,418
• Since beginning of last month:
  • Site-wide: 68,681

A Newcastle disease virus (NDV) expressing membrane-anchored spike as a cost-effective inactivated SARS-CoV-2 vaccine

• Downloaded 2,111 times
• Download rankings, all-time:
  • Site-wide: 10,940
  • In microbiology: 623
• Year to date:
  • Site-wide: 59,290
• Since beginning of last month:
  • Site-wide: 67,848

Collaboration between the Fab and Fc contribute to maximal protection against SARS-CoV-2 in nonhuman primates following NVX-CoV2373 subunit vaccine with Matrix-M™ vaccination

• Downloaded 2,056 times
• Download rankings, all-time:
  • Site-wide: 11,408
  • In immunology: 433
• Year to date:
  • Site-wide: 10,802
• Since beginning of last month:
  • Site-wide: 6,727

A public vaccine-induced human antibody protects against SARS-CoV-2 and emerging variants

• Downloaded 1,904 times
• Download rankings, all-time:
  • Site-wide: 12,766
  • In immunology: 448
• Year to date:
  • Site-wide: 34,979
• Since beginning of last month:
  • Site-wide: 43,064

Limited intestinal inflammation despite diarrhea, fecal viral RNA and SARS-CoV-2-specific IgA in patients with acute COVID-19

• Downloaded 1,890 times
• Download rankings, all-time:
  • Site-wide: 12,895
  • In gastroenterology: 11
• Year to date:
  • Site-wide: 24,429
• Since beginning of last month:
  • Site-wide: 31,183

A High Through-put Assay for Circulating Antibodies Directed against the S Protein of Severe Acute Respiratory Syndrome Corona virus 2

• Downloaded 1,765 times
• Download rankings, all-time:
  • Site-wide: 14,288
  • In infectious diseases: 1,814
• Year to date:
  • Site-wide: 93,440
• Since beginning of last month:
  • Site-wide: 101,131

SARS-CoV-2 infection severity is linked to superior humoral immunity against the spike

• Downloaded 1,586 times
• Download rankings, all-time:
  • Site-wide: 16,766
  • In immunology: 562
• Year to date:
  • Site-wide: 98,242
• Since beginning of last month:
  • Site-wide: 128,221

Sterilizing Immunity against SARS-CoV-2 Infection in Mice by a Single-Shot and Modified Imidazoquinoline TLR7/8 Agonist-Adjuvanted Recombinant Spike Protein Vaccine

• Downloaded 1,356 times
• Download rankings, all-time:
  • Site-wide: 21,374
  • In microbiology: 1,247
• Year to date:
  • Site-wide: 49,220
• Since beginning of last month:
  • Site-wide: 50,869

Reduced neutralizing activity of post-SARS-CoV-2 vaccination serum against variants B.1.617.2, B.1.351, B.1.1.7+E484K and a sub-variant of C.37

• Downloaded 1,337 times
• Download rankings, all-time:
  • Site-wide: 21,838
  • In infectious diseases: 2,277
• Year to date:
  • Site-wide: 58,271
• Since beginning of last month:
  • Site-wide: 73,207

Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strains

• Downloaded 1,281 times
• Download rankings, all-time:
  • Site-wide: 23,353
  • In microbiology: 1,425
• Year to date:
  • Site-wide: 19,524
• Since beginning of last month:
  • Site-wide: 21,207

High attack rates of SARS-CoV-2 infection through household-transmission: a prospective study

• Downloaded 1,233 times
• Download rankings, all-time:
  • Site-wide: 24,814
  • In infectious diseases: 2,413
• Year to date:
  • Site-wide: 62,757
• Since beginning of last month:
  • Site-wide: 90,179

Discovery of a SARS-CoV-2 Broadly-Acting Neutralizing Antibody with Activity against Omicron and Omicron + R346K Variants

• Downloaded 1,180 times
• Download rankings, all-time:
  • Site-wide: 26,508
  • In microbiology: 2,501
• Year to date:
  • Site-wide: 1,319
• Since beginning of last month:
  • Site-wide: 15,647

The Spike-specific IgA in milk commonly-elicited after SARS-Cov-2 infection is concurrent with a robust secretory antibody response, exhibits neutralization potency strongly correlated with IgA binding, and is highly durable over time

• Downloaded 1,164 times
• Download rankings, all-time:
  • Site-wide: 27,079
  • In allergy and immunology: 95
• Year to date:
  • Site-wide: 33,845
• Since beginning of last month:
  • Site-wide: 15,289

Differential T cell reactivity to seasonal coronaviruses and SARS-CoV-2 in community and health care workers

• Downloaded 1,142 times
• Download rankings, all-time:
  • Site-wide: 27,882
  • In infectious diseases: 2,644
• Year to date:
  • Site-wide: 35,488
• Since beginning of last month:
  • Site-wide: 26,894

Immune response to 2-dose BNT162b2 vaccination and risk of SARS-CoV-2 breakthrough infection: The Shieldvacc-2 study

• Downloaded 1,078 times
• Download rankings, all-time:
  • Site-wide: 30,410
  • In epidemiology: None
• Year to date:
  • Site-wide: 1,515
• Since beginning of last month:
  • Site-wide: 5,046

Trivalent NDV-HXP-S vaccine protects against phylogenetically distant SARS-CoV-2 variants of concern in mice

• Downloaded 954 times
• Download rankings, all-time:
  • Site-wide: 36,437
  • In immunology: None
• Year to date:
  • Site-wide: 1,820
• Since beginning of last month:
  • Site-wide: 4,933

A public broadly neutralizing antibody class targets a membrane-proximal anchor epitope of influenza virus hemagglutinin

• Downloaded 890 times
• Download rankings, all-time:
  • Site-wide: 40,451
  • In immunology: 1,453
• Year to date:
  • Site-wide: 35,483
• Since beginning of last month:
  • Site-wide: 11,745

A Newcastle disease virus-vector expressing a prefusion-stabilized spike protein of SARS-CoV-2 induces protective immune responses against prototype virus and variants of concern in mice and hamsters

• Downloaded 871 times
• Download rankings, all-time:
  • Site-wide: 41,742
  • In immunology: 1,331
• Year to date:
  • Site-wide: 65,053
• Since beginning of last month:
  • Site-wide: 60,149

Real Time Investigation of a large Nosocomial Influenza A Outbreak Informed by Genomic Epidemiology

• Downloaded 791 times
• Download rankings, all-time:
  • Site-wide: 48,164
  • In infectious diseases: 3,391
• Year to date:
  • Site-wide: 124,352
• Since beginning of last month:
  • Site-wide: 123,002

Murine monoclonal antibodies against RBD of SARS-CoV-2 neutralize authentic wild type SARS-CoV-2 as well as B.1.1.7 and B.1.351 viruses and protect in vivo in a mouse model in a neutralization dependent manner

• Downloaded 695 times
• Download rankings, all-time:
  • Site-wide: 57,841
  • In microbiology: 3,349
• Year to date:
  • Site-wide: 126,114
• Since beginning of last month:
  • Site-wide: 123,701

Structure of a germline-like human antibody defines a neutralizing epitope on the SARS-CoV-2 spike NTD

• Downloaded 661 times
• Download rankings, all-time:
  • Site-wide: 61,962
  • In immunology: 2,025
• Year to date:
  • Site-wide: 46,564
• Since beginning of last month:
  • Site-wide: 37,682

Seroprevalence of SARS-CoV-2 during pregnancy and associated outcomes: results from an ongoing prospective cohort study, New York City

• Downloaded 647 times
• Download rankings, all-time:
  • Site-wide: 63,803
  • In obstetrics and gynecology: 85
• Year to date:
  • Site-wide: 33,110
• Since beginning of last month:
  • Site-wide: 8,533

Functionality of the putative surface glycoproteins of the Wuhan spiny eel influenza virus

• Downloaded 603 times
• Download rankings, all-time:
  • Site-wide: 69,939
  • In microbiology: 4,133
• Year to date:
  • Site-wide: 135,404
• Since beginning of last month:
  • Site-wide: 74,116

Detection of velogenic avian paramyxoviruses in rock doves in New York City, New York

• Downloaded 597 times
• Download rankings, all-time:
  • Site-wide: 70,826
  • In microbiology: 12,461
• Year to date:
  • Site-wide: 5,557
• Since beginning of last month:
  • Site-wide: 50,303

The Serological Sciences Network (SeroNet) for COVID-19: Depth and Breadth of Serology Assays and Plans for Assay Harmonization

• Downloaded 553 times
• Download rankings, all-time:
  • Site-wide: 77,790
  • In infectious diseases: None
• Year to date:
  • Site-wide: 4,283
• Since beginning of last month:
  • Site-wide: 10,304

Longitudinal analysis of SARS-CoV-2 seroprevalence using multiple serology platforms

• Downloaded 549 times
• Download rankings, all-time:
  • Site-wide: 78,506
  • In infectious diseases: 4,399
• Year to date:
  • Site-wide: 82,925
• Since beginning of last month:
  • Site-wide: 45,441

Vaccination with B.1.1.7, B.1.351 and P.1 variants protects mice from challenge with wild type SARS-CoV-2

• Downloaded 522 times
• Download rankings, all-time:
  • Site-wide: 83,419
  • In immunology: 2,486
• Year to date:
  • Site-wide: 94,592
• Since beginning of last month:
  • Site-wide: 88,157

Safety and Immunogenicity of An Egg-Based Inactivated Newcastle Disease Virus Vaccine Expressing SARS-CoV-2 Spike: Interim Results of a Randomized, Placebo-Controlled, Phase 1/2 Trial in Vietnam

• Downloaded 511 times
• Download rankings, all-time:
  • Site-wide: 85,533
  • In infectious diseases: 4,815
• Year to date:
  • Site-wide: 4,811
• Since beginning of last month:
  • Site-wide: 47,838

Reduced antibody activity against SARS-CoV-2 B.1.617.2 Delta virus in serum of mRNA-vaccinated patients receiving TNF-alpha inhibitors

• Downloaded 449 times
• Download rankings, all-time:
  • Site-wide: 98,801
  • In infectious diseases: 4,901
• Year to date:
  • Site-wide: 64,571
• Since beginning of last month:
  • Site-wide: 88,363

Rapid homogeneous assay for detecting antibodies against SARS-CoV-2

• Downloaded 371 times
• Download rankings, all-time:
  • Site-wide: 118,054
  • In infectious diseases: 5,414
• Year to date:
  • Site-wide: 108,658
• Since beginning of last month:
  • Site-wide: 88,194

High Initial Titres of Anti-Spike Antibodies following SARS-CoV-2 Infection is Associated with Faster Decay Rates at Four Months Follow-Up

• Downloaded 356 times
• Download rankings, all-time:
  • Site-wide: 122,239
  • In infectious diseases: 5,727
• Year to date:
  • Site-wide: 66,217
• Since beginning of last month:
  • Site-wide: 34,462

SARS-CoV-2 spike-binding antibody longevity and protection from re-infection with antigenically similar SARS-CoV-2 variants

• Downloaded 345 times
• Download rankings, all-time:
  • Site-wide: 125,317
  • In infectious diseases: None
• Year to date:
  • Site-wide: 8,761
• Since beginning of last month:
  • Site-wide: 33,199

Monoclonal antibodies targeting the influenza virus N6 neuraminidase

• Downloaded 333 times
• Download rankings, all-time:
  • Site-wide: 128,607
  • In microbiology: 8,487
• Year to date:
  • Site-wide: 154,610
• Since beginning of last month:
  • Site-wide: 189,509

The antibody landscapes against Group 1 and 2 influenza virus hemagglutinin following AS03 and MF59 adjuvanted H5N1 vaccination

• Downloaded 314 times
• Download rankings, all-time:
  • Site-wide: 134,170
  • In infectious diseases: 6,009
• Year to date:
  • Site-wide: 65,260
• Since beginning of last month:
  • Site-wide: 98,523

Novel epitopes of human monoclonal antibodies targeting the influenza virus N1 neuraminidase

• Downloaded 305 times
• Download rankings, all-time:
  • Site-wide: 136,949
  • In microbiology: 9,393
• Year to date:
  • Site-wide: 126,311
• Since beginning of last month:
  • Site-wide: 136,049

Integrated immune networks in SARS-CoV-2 infected pregnant women reveal differential NK cell and unconventional T cell activation

• Downloaded 302 times
• Download rankings, all-time:
  • Site-wide: 137,835
  • In infectious diseases: 6,168
• Year to date:
  • Site-wide: 65,237
• Since beginning of last month:
  • Site-wide: 49,960

Choosing the right tool for the job: A comprehensive assessment of serological assays for SARS-CoV-2 as surrogates for authentic virus neutralization

• Downloaded 293 times
• Download rankings, all-time:
  • Site-wide: 140,589
  • In infectious diseases: 6,319
• Year to date:
  • Site-wide: 64,542
• Since beginning of last month:
  • Site-wide: 28,623

Potent and pan-neutralization of SARS-CoV-2 variants of concern by DARPins

• Downloaded 271 times
• Download rankings, all-time:
  • Site-wide: 147,023
  • In bioengineering: None
• Year to date:
  • Site-wide: 12,679
• Since beginning of last month:
  • Site-wide: 1,666

Permissive Omicron breakthrough infections in individuals with binding or neutralizing antibodies to ancestral SARS-CoV-2

• Downloaded 243 times
• Download rankings, all-time:
  • Site-wide: 155,324
  • In infectious diseases: None
• Year to date:
  • Site-wide: 14,852
• Since beginning of last month:
  • Site-wide: 18,975

Maternal cytokine response after SARS-CoV-2 infection during pregnancy

• Downloaded 239 times
• Download rankings, all-time:
  • Site-wide: 156,214
  • In immunology: 5,054
• Year to date:
  • Site-wide: 15,236
• Since beginning of last month:
  • Site-wide: 36,245